Standout Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer 2020 2026 2022 2024748
  1. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer (2020)
    Kohei Shitara, Yung‐Jue Bang et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 3 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
1 intermediate paper

Works of Daisuke Sakai being referenced

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
2020 Standout
Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
2018

Author Peers

Author Last Decade Papers Cites
Daisuke Sakai 1278 913 460 494 119 2.2k
Yoichi Naito 1636 1032 266 594 148 2.6k
Minkyu Jung 1175 860 438 476 139 2.1k
Yasutoshi Kuboki 1963 1126 424 530 141 2.6k
Florian Grabellus 785 718 611 775 101 2.7k
Cristina Grávalos 1627 939 416 501 80 2.2k
Jifang Gong 1651 880 504 757 143 2.7k
Sang Yun Ha 1154 859 640 730 151 3.0k
María Alsina 1303 1258 756 572 105 2.4k
Tania Fleitas 1064 975 508 552 58 2.1k
Su‐Jin Shin 911 820 374 439 148 2.0k

All Works

Loading papers...

Rankless by CCL
2026